Seeing Is Believing
Currently out of the existing stock ratings of Biren Amin, 26 are a HOLD (16.35%), 132 are a BUY (83.02%), 1 are a SELL (0.63%).
Analyst Biren Amin works with a stock forecast success ratio of 54.83% fulfilled within 240.88 days on average. Previously, Biren Amin worked at JEFFERIES.
Biren Amin’s has documented 310 price targets and ratings displayed on 34 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CCCC, C4 Therapeutics at 10-Aug-2023.
Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$-3.69 (-31.57%)
7.85
10 months 27 days ago
2/2 (100%)
$6.27 (362.43%)
358
Buy
8.15
$-3.54 (-30.28%)
8.15
1 years 1 months 17 days ago
2/4 (50%)
$6.3 (340.54%)
433
Buy
8
$-3.69 (-31.57%)
11
2 years 1 months 29 days ago
2/3 (66.67%)
$5.1 (175.86%)
841
Buy
6.87
$5.74 (507.96%)
3 years 1 months 16 days ago
0/1 (0%)
$3.72 (118.10%)
Buy
7
$4.56 (186.89%)
7 years 11 days ago
0/2 (0%)
$4.6 (103.40%)
What Year was the first public recommendation made by Biren Amin?